- Telehealth Visits
- Insurance plan information
Elizabeth E. Rogers, MD
Neonatology- Telehealth Visits
- Insurance plan information
Elizabeth E. Rogers, MD
Neonatology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Elizabeth E. Rogers is a neonatologist and co-director of the Intensive Care Nursery Follow-Up Program. She specializes in neurodevelopmental and behavioral pediatrics for critically ill premature infants and other at-risk newborns in the intensive care nursery of UCSF Benioff Children's Hospital. Her research focuses on developmental and social-behavioral outcomes for these infants and aims to identify risk factors for impairment.
Rogers earned her medical degree from Stanford University School of Medicine in 2003. She completed a residency at UCSF in 2006 and a fellowship in neonatology in 2010.
A member of the American Academy of Pediatrics, Rogers has received the Abraham Rudolph Award for UCSF Pediatric Residents, the UCSF Department of Pediatrics Medical Student Teaching Award and the UCSF Department of Pediatrics Postgraduate Fellow Teaching Award. She speaks fluent Russian.
Education & training
Board certification
- Neonatal-Perinatal Medicine, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Fellowship
- Neonatology, UCSF Graduate Medical Education
Residency
- Pediatrics, UCSF Graduate Medical Education
Internship
- Pediatrics, UCSF Graduate Medical Education
Degree
- MD, Stanford University School of Medicine
My expertise
Specialties
- Neonatology
Clinical Trials query: q=health_gateway_id_ss%3A%28%22991%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22991%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.